DrKids Himasal Natural Nasal Saline Solution — Class II drug recall D-0133-2020
Terminated recall by Unipharma, Llc., reported 2019-10-16, distributed nationwide. CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bac
| Recall number | D-0133-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Unipharma, Llc., Tamarac, FL, United States |
| Recall initiated | 2019-09-23 |
| Classified | 2019-10-09 |
| Reported by FDA | 2019-10-16 |
| Terminated | 2021-03-23 |
| Distributed | Nationwide (US) |
| Quantity | 456 cartons |
| Reason classes | microbial contamination, cgmp |
| Pathogens | burkholderia |
| UPC / GTIN / UDI-DI | 00370302446098 |
| Lot numbers | 70003, 70005, 70006, 80003 |
| Expiration dates | 2019-10-31, 2019-11-30, 2020-01-31 |
Product
DrKids Himasal Natural Nasal Saline Solution, packaged in Pre-measured Singe-Use Vials a) 0.5 mL Each (20 count) UPC 37030244608; b) 1.5 mL Each (20 count) UPC 370302446098, Manufactured in USA by: UNIPHARMA, LLC Tamarac, FL 33321
Reason for recall
CGMP Deviations: Recall as a precautionary measure due to potential risk of product contamination with the bacteria B. cepacia.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0133-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.